Insulin Resistance
Insulin Resistance Isn't Just One Thing: What Happens in Your Muscle, Liver, and Fat
Insulin resistance doesn't work the same way everywhere. What goes wrong in muscle differs from what happens in the liver — and fat cells may influence both.

When people hear insulin resistance, it often sounds like one switch:
You're either insulin resistant or you're not.
The reality is more interesting.
Your muscles can become resistant to insulin in one way, your liver in another, and your fat cells in another.
And those differences help explain something that otherwise seems confusing:
Why one person first notices high blood sugar after meals...
while another person's biggest problem is their fasting glucose first thing in the morning.
To understand why, it helps to stop thinking of insulin resistance as one disease happening everywhere at once.
First: what is insulin supposed to do?
Insulin is a hormone released primarily in response to rising nutrients in the bloodstream, especially glucose.
But insulin doesn't give the same instruction to every tissue.
In skeletal muscle, one major message is:
Take up glucose and store some of it as glycogen.
In the liver:
Slow down glucose production and store incoming fuel.
In fat tissue:
Reduce the release of stored fatty acids and help manage energy storage.
Insulin resistance means those tissues become less responsive to insulin's signal.
The important part is that the signal — and therefore the failure — isn't identical everywhere.
Muscle insulin resistance: glucose has a harder time getting in
Skeletal muscle is enormously important for glucose control.
After a carbohydrate-containing meal, muscle is one of the body's major destinations for glucose.
Insulin helps activate processes that allow muscle cells to take glucose out of the bloodstream and either:
- burn it for energy
- or store it as glycogen for later
When muscle becomes insulin resistant, the same amount of insulin produces less glucose uptake.
So the pancreas has a choice.
It can allow glucose to rise...
or it can produce more insulin to compensate.
Early in insulin resistance, it often does the second.
That creates an important situation:
Blood glucose can still look fairly normal while insulin levels are already considerably higher.
The glucose number may not look alarming yet because the pancreas is essentially working harder to produce the same result.
Think of insulin like knocking on a door
Imagine insulin normally knocks once:
Knock.
The muscle opens the door and glucose enters.
With insulin resistance:
Knock. Knock. Knock. Knock.
Eventually the door still opens.
But it took much more insulin to accomplish the same thing.
That is why normal glucose does not necessarily equal normal insulin sensitivity.
Why muscle matters so much after meals
Researchers including Ralph DeFronzo and Gerald Shulman have spent decades studying this.
One of the characteristic features of muscle insulin resistance is impaired glucose disposal after carbohydrate is consumed.
Instead of efficiently moving much of that incoming glucose into muscle glycogen, more glucose remains available in circulation or gets redirected elsewhere.
That helps explain why post-meal glucose abnormalities can appear before fasting glucose becomes obviously abnormal.
It also explains why physical activity can be so powerful.
Contracting muscle can increase glucose uptake through mechanisms that are not entirely dependent on insulin.
In plain English:
Using your muscles gives glucose another route out of the bloodstream.
That is one reason even something as simple as walking after a meal can change the glucose response.
Liver insulin resistance: the faucet doesn't shut off properly
The liver has almost the opposite job.
While muscle largely takes glucose in, the liver can also put glucose into the bloodstream.
That's important.
If you go eight or ten hours without eating, your brain still needs fuel.
Your liver helps keep glucose available by:
- breaking down stored glycogen
- producing new glucose
When insulin rises after a meal, one of its normal jobs is to tell the liver:
We've got incoming fuel. You can slow down glucose production now.
In an insulin-sensitive liver, that signal works well.
In an insulin-resistant liver, it may not.
The liver can continue releasing glucose when the body already has plenty available.
So now you have two sources contributing to blood glucose:
glucose coming in from the meal
plus
glucose still being released by the liver.
That's one reason liver insulin resistance is strongly connected with higher fasting glucose.
This is also why morning glucose can be confusing
Someone may wake up with a blood sugar reading of 120 mg/dL and think:
"How can my sugar be high? I haven't eaten anything since dinner."
That's exactly the point.
The glucose didn't necessarily come from breakfast.
It can come from the liver.
The liver was supplying fuel overnight.
If insulin isn't suppressing that output efficiently, fasting glucose can rise.
We cover this phenomenon more deeply in our article on why morning blood sugar can be high.
Fat-cell insulin resistance: stored energy starts leaking out
Fat tissue is often discussed as if its only job is making someone heavier.
That's far too simplistic.
Healthy adipose tissue is an important energy-storage organ.
One of insulin's jobs in fat cells is to suppress lipolysis — the breakdown of stored triglycerides into fatty acids that can be released into circulation.
When fat cells become insulin resistant, insulin becomes less effective at applying that brake.
More fatty acids may escape into the bloodstream.
And that can create problems elsewhere.
Elevated delivery of fatty acids to the liver can contribute to:
- increased liver fat
- increased triglyceride production
- increased glucose production
Fat-derived metabolites accumulating in liver and muscle are also associated with impaired insulin signaling in those tissues.
This is where the different forms of insulin resistance begin to feed into one another.
The overflow idea — useful, but incomplete
Insulin resistance is often explained using an overflow model.
The basic analogy is easy to understand:
If energy-storage tissues are already overloaded, forcing even more fuel into them becomes increasingly difficult.
There is something useful in that picture.
Research from Gerald Shulman's group and others has shown strong links between ectopic fat — fat stored in places such as the liver and skeletal muscle — and insulin resistance.
But the biology is more complicated than simply:
"The cells are full."
Specific lipid metabolites, signaling pathways, genetics, inflammation, physical inactivity, energy balance, fat distribution, and the ability of adipose tissue to safely store excess energy can all matter.
So "overflow" is a helpful mental model.
It isn't the complete mechanism.
Where you store fat may matter as much as how much you have
This also explains a phenomenon that surprises many people.
Not everyone with obesity develops severe insulin resistance.
And not everyone with insulin resistance looks obviously overweight.
Two people can have similar body weights but very different amounts of:
- visceral fat
- liver fat
- intramuscular fat
- subcutaneous fat
Subcutaneous fat — the fat underneath the skin — can often act as a relatively safe storage compartment.
Problems may become more likely when excess energy begins accumulating in places less suited for long-term fat storage, particularly the liver and other ectopic sites.
The 2026 ADA Standards recognize that some people who do not meet standard BMI cutoffs for overweight or obesity can still have metabolically significant abdominal or ectopic fat.
That is one reason the scale alone cannot tell you someone's metabolic health.
So which comes first: muscle, liver, or fat?
There isn't one universal sequence for every person.
But an important body of research suggests that skeletal-muscle insulin resistance can appear early.
If muscle becomes less effective at storing incoming carbohydrate as glycogen, more of that energy can be redirected toward the liver.
Over time, increased liver fat and impaired hepatic insulin sensitivity can contribute to:
- increased glucose production
- higher triglycerides
- higher fasting glucose
Meanwhile, insulin-resistant fat tissue may release more fatty acids, adding another stream of fuel entering the liver.
Now the problem is no longer isolated to one tissue.
It's a network.
Get the research, without the noise.
Practical, sourced writing on blood sugar and metabolic health. One email a week.
One email a week. Unsubscribe any time. See our privacy policy.
And then the pancreas has to compensate
There is another player we haven't talked about yet:
the pancreatic beta cells.
When tissues become less sensitive to insulin, the pancreas often responds by secreting more of it.
For a while, that compensation can work remarkably well.
Glucose stays fairly normal.
Insulin rises.
But type 2 diabetes generally develops when the beta cells can no longer produce enough insulin to compensate for the body's degree of insulin resistance.
This is why DeFronzo described the core problem in type 2 diabetes as involving:
- muscle insulin resistance
- liver insulin resistance
- progressive beta-cell dysfunction
He later expanded the model to include several additional organs and hormonal systems — the well-known "ominous octet."
The important lesson is simple:
Type 2 diabetes is not merely "too much sugar in the blood."
High blood sugar is the visible result of a much larger metabolic process.
Why exercise can affect more than one part of the system
This is also why physical activity deserves more attention than simply:
"Exercise burns calories."
That undersells it.
Exercise can help skeletal muscle become more effective at taking up and storing glucose.
Resistance training can increase the amount of metabolically active muscle available to dispose of glucose.
Regular physical activity can also improve insulin sensitivity even without dramatic weight loss.
And reducing excess visceral and liver fat can improve hepatic insulin sensitivity.
So movement doesn't simply burn off yesterday's dinner.
It changes how your body handles tomorrow's dinner.
That's a much more important concept.
The Health Facts takeaway
The phrase insulin resistance makes the problem sound simpler than it is.
Your body isn't one big glucose tank.
It's a network of specialized tissues doing different jobs.
Muscle insulin resistance can make it harder to dispose of glucose after meals.
Liver insulin resistance can allow too much glucose to enter the bloodstream even when you haven't eaten.
Fat-cell insulin resistance can increase the release of fatty acids and influence what happens in both the liver and muscle.
And your pancreas may compensate for all of this by producing more insulin.
That leads to a bigger way of thinking about metabolic health.
The goal shouldn't only be:
"How do I get today's glucose number lower?"
A better question is:
"How do I make the whole system better at handling fuel?"
When you're metabolically flexible, your body is better able to respond appropriately to changing conditions:
eat → store → move → use fuel → fast → switch fuels → eat again.
That is very different from forcing one laboratory number lower while ignoring what is happening underneath it.
And it's why improving metabolic health usually involves several levers working together:
- food quality and quantity
- muscle activity
- resistance training
- sleep
- body composition
- visceral and liver fat
- sustainable eating patterns
The glucose reading is what you see.
The machinery underneath it is what produces the reading.
Sources
- 1. Insulin Resistance & Prediabetes. National Institute of Diabetes and Digestive and Kidney Diseases.
- 2. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus. Diabetes (American Diabetes Association), 2009. doi:10.2337/db09-9028
- 3. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care (American Diabetes Association), 2009. doi:10.2337/dc09-S302
- 4. The Pathogenesis of Insulin Resistance: Integrating Signaling Pathways and Substrate Flux. Journal of Clinical Investigation, 2016. doi:10.1172/JCI77812
- 5. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease. New England Journal of Medicine, 2014. doi:10.1056/NEJMra1011035
- 6. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care (American Diabetes Association), 2026. doi:10.2337/dc26-S008
Comments
No comments yet.
Leave a comment
Comments are moderated. Be kind and stay on topic.



